Coagulation disorders in liver disease.

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMID 11928081)

Published in Semin Liver Dis on February 01, 2002

Authors

Lucio Amitrano1, Maria A Guardascione, Vincenzo Brancaccio, Antonio Balzano

Author Affiliations

1: Gastroenterology Unit, A. Cardarelli Hospital, Via Morghen 92, 80129 Naples, Italy. luamitra@tin.it

Associated clinical trials:

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction | NCT00816127

Articles citing this

Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39

Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World J Surg (2012) 1.18

New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17

Spectrum of anemia associated with chronic liver disease. World J Gastroenterol (2009) 1.07

Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care (2009) 1.03

Alcohol-induced changes in the brain as assessed by MRI and CT. Eur Radiol (2009) 0.98

Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol (2006) 0.98

Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study. Crit Care (2006) 0.95

Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor. Br J Clin Pharmacol (2013) 0.93

Blood platelet and monocyte activations and relation to stages of liver cirrhosis. World J Gastroenterol (2005) 0.92

Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C. World J Gastroenterol (2006) 0.92

The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J (2011) 0.91

Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. ScientificWorldJournal (2014) 0.90

Preventative effects of caffeic Acid phenyl ester on cadmium intoxication induced hematological and blood coagulation disturbances and hepatorenal damage in rats. ISRN Hematol (2014) 0.83

Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up. Heart (2005) 0.82

The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82

Special issues involving periprosthetic infection in immunodeficiency patients. Open Orthop J (2013) 0.82

Plasma and platelet serotonin levels in patients with liver cirrhosis. World J Gastroenterol (2007) 0.82

CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity. J Clin Invest (2016) 0.81

Serum hyaluronic acid concentration in Fontan circulation: correlation with hepatic function and portal vein hemodynamics. Pediatr Cardiol (2013) 0.78

Randomized, controlled comparison of advanced hemostatic pads in hepatic surgical models. ISRN Surg (2014) 0.77

Serotype-specific host responses in rhesus macaques after primary dengue challenge. Am J Trop Med Hyg (2013) 0.77

Evaluation of coagulation parameters and liver enzymes among alcohol drinkers in Port Harcourt, Nigeria. Int J Gen Med (2013) 0.77

Monitoring coagulation proteins during progression of liver disease. Indian J Clin Biochem (2014) 0.75

Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect Dis (2017) 0.75

Impact of sustained virus elimination on natural anticoagulant activity in patients with chronic viral hepatitis C. Bosn J Basic Med Sci (2013) 0.75

A Cell-type-resolved Liver Proteome. Mol Cell Proteomics (2016) 0.75

Modelling Factors Causing Mortality in Oesophageal VaricesPatients in King Abdul Aziz University Hospital. Oman Med J (2009) 0.75

Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational Study. Med Sci Monit (2016) 0.75

Purpura fulminans in a newborn infant with galactosemia. Eur J Pediatr (2009) 0.75

Association between plasma fibrinogen levels and mortality in acute-on-chronic hepatitis B liver failure. Dis Markers (2015) 0.75

Liver dysfunction as an important predicting risk factor in patients undergoing cardiac surgery: a systematic review and meta-analysis. Int J Clin Exp Med (2015) 0.75

Thromboelastographic Evaluation of Coagulation in Patients With Liver Disease. Ann Lab Med (2017) 0.75

Neonatal neuroblastoma with adrenal primary and metastasis to the liver: A case report and a review of literature. Afr J Paediatr Surg (2017) 0.75

Fibrinogen alpha C chain 5.9 kDa fragment (FIC5.9), a biomarker for various pathological conditions, is produced in post-blood collection by fibrinolysis and coagulation factors. Clin Proteomics (2016) 0.75

Haemostatic Profile of Patients with Chronic Liver Disease- its Correlation with Severity and Outcome. J Clin Diagn Res (2017) 0.75

Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma. World J Surg (2008) 0.75

Acute and sub-acute toxicity study of a Pakistani polyherbal formulation. BMC Complement Altern Med (2017) 0.75

A cerebrovascular event after single-dose administration of recombinant factor VIIa in a patient with esophageal variceal bleeding. Dig Dis Sci (2006) 0.75

Articles by these authors

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood (2004) 4.70

Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol (2004) 1.62

Relationship of sliding hiatus hernia to gastroesophageal reflux disease: a possible role for Helicobacter pylori infection? Dig Dis Sci (2003) 1.51

Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation: an 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia. Thromb Haemost (2005) 1.50

Helicobacter pylori and pancreatic disease. JOP (2003) 1.43

Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol (2010) 1.35

MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol (2005) 1.33

Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol (2007) 1.13

Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin. Haematologica (2004) 1.12

Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment. BMJ (2003) 1.07

Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. Dis Colon Rectum (2002) 1.05

Impact of prothrombotic mutations and family history on the occurrence of intra-uterine fetal deaths. Haematologica (2002) 0.99

Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas (2003) 0.91

Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial. J Clin Gastroenterol (2005) 0.88

Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome. Blood Coagul Fibrinolysis (2008) 0.85

Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption. World J Gastroenterol (2011) 0.81

In-hospital mortality in non-variceal upper gastrointestinal bleeding Forrest 1 patients. Scand J Gastroenterol (2008) 0.81

Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation. Haematologica (2004) 0.81

A novel G-to-A mutation in the intron-N of the protein S gene leading to abnormal RNA splicing in a patient with protein S deficiency. Haematologica (2003) 0.79

Contrast-free endoscopic stent insertion in malignant biliary obstruction. World J Gastroenterol (2007) 0.78

Hypoxic hepatitis occurring in cirrhosis after variceal bleeding: still a lethal disease. J Clin Gastroenterol (2012) 0.77

Hepatic vein thrombosis leading to fulminant hepatic failure in a case of acute non-promyelocytic myelogenous leukemia. Blood Coagul Fibrinolysis (2006) 0.77

Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosis. Clin Appl Thromb Hemost (2010) 0.77

FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile. Thromb Haemost (2002) 0.77

Portal and mesenteric venous thrombosis in cirrhotic patients. Gastroenterology (2002) 0.76

Tinidazole: from protozoa to Helicobacter pylori--the past, present and future of a nitroimidazole with peculiarities. Expert Rev Anti Infect Ther (2004) 0.76

Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation. Thromb Haemost (2008) 0.76

Ulcerative colitis exacerbating after placement of intragastric balloon for the treatment of obesity. Inflamm Bowel Dis (2008) 0.76

Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation. Thromb Haemost (2006) 0.76

Factor XIII in primary antiphospholipid syndrome. J Rheumatol (2005) 0.75

C-reactive protein in primary antiphospholipid syndrome. J Rheumatol (2007) 0.75

Peptic ulcer, Helicobacter pylori, and reflux symptoms. Gastrointest Endosc (2003) 0.75

Janus kinase-2 mutation, cirrhosis and splanchnic vein thrombosis. Eur J Gastroenterol Hepatol (2008) 0.75

Management of variceal haemorrhage in cirrhosis: the relevance of the risk stratification. Gut (2010) 0.75

Acute portal and mesenteric thrombosis: unusual presentation of cytomegalovirus infection. Eur J Gastroenterol Hepatol (2006) 0.75

Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis. Eur J Gastroenterol Hepatol (2012) 0.75

The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation. Haematologica (2003) 0.75

Preventing adverse obstetric outcomes in women with genetic thrombophilia. Fertil Steril (2002) 0.75

Surgical treatment of non-variceal upper gastrointestinal bleeding: our experience with 1482 patients. Chir Ital (2008) 0.75

Survival in primary antiphospholipid syndrome. A single-centre cohort study. Thromb Haemost (2016) 0.75

Corrigendum: Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study. Am J Gastroenterol (2015) 0.75

Identification of six novel mutations in type I antithrombin deficient Italian families. Haematologica (2004) 0.75

The corner of the gastroenterologist: what colonoscopy can do, what to ask to radiologist. Eur J Radiol (2006) 0.75